The Smallpox Eradication Program held frequent regional meetings, seminars, and training seminars. Participants included national programme staff, WHO smallpox advisers, and smallpox eradication staff from the regional offices and WHO Headquarters. WHO Regional Officers from the 4 endemic regions were invited to all meetings from 1967 to 1970 and to the 1972 seminar in New Delhi, India.
Note: This section is not complete. It includes only those meetings for which documents have so far been located.
| Title | Authors | Source | URL |
|---|---|---|---|
| Report of the Inter-Regional Smallpox Conference | -- | WHO/Smallpox/17 | WHO: 10665/67156 |
| Epidemiological considerations of smallpox control | Soewondo R | SEA/SPX/Conf 3 | |
| Report on the [Peruvian] smallpox vaccination campaign carried out during the period October 1950 - December 1955 Presented at the Seminar on Smallpox Vaccination, Lima, Peru, 20-25 Aug 1956 |
de la Fuente EA | WHO/Smallpox/12 | WHO: 10665/67146 |
| Annual report of the national anti-smallpox vaccination programme in the Republic of Colombia, 1959 | WHO/Smallpox/13 | DAH: Chesney Med Arch | |
| Smallpox in India as assessed from the incidence of reported smallpox cases per 100,000 population by districts | Patnaik LC | SEA/SPX/Conf 8 | |
| Organization of a smallpox eradication campaign | Arasteh C | SEA/SPX/Conf 10 | |
| Local and social aspects of the smallpox eradication campaign | Pandit CG | SEA/SPX/Conf 4 | |
| Educational aspects of the smallpox eradication campaign | Ramakrishna V | SEA/SPX/Conf 9 | |
| Eradication vs control of smallpox | Frederiksen H | SEA/SPX/Conf 5 | |
| Evaluation of smallpox vaccination programs [Evaluation of smallpox vaccination programs] French |
Cruickshank R | WHO/Smallpox/15 English (incomplete) [French, complete] |
WHO: 10665/67152 [WHO: 10665/67153] |
| Smallpox vaccine and vaccination technique | Ahmad N | SEA/SPX/Conf 6 | |
| Co-ordination of smallpox eradication campaign with other campaigns and with the general activities of the public health service | Chandravimol P | SEA/SPX/Conf 7 | |
| International aspects of smallpox eradication | WHO Secretariat | WHO/Smallpox/14 | DAH: Chesney Med Arch |
| Compulsory or voluntary vaccination [Reference document] | WHO Secretariat | A13/Technical Discussions/2 | WHO: 10665/134370 |
| Title | Authors | Source | URL |
|---|---|---|---|
| WHO Expert Committee on Smallpox. 1st Report | WHO | Technical Report Series No. 283 | WHO: 10665/40597 |
| Draft agenda | WHO | Smallpox/WP/1 | DAH: Chesney Med Arch |
| Review of smallpox situation in the world | WHO | Smallpox/WP/12 | WHO: 10665/67663 |
| Factors involved in transmission of smallpox and duration of immunity | Dixon CW | Smallpox/WP/7 | WHO: 10665/67697 |
| A study of 240 cases of haemorrhagic smallpox | Rao AR | Smallpox/WP/22 | WHO: 10665/67676 |
| Correlation between antibody levels and vaccination reaction | Benenson AS | Smallpox/WP/15 | WHO: 10665/67671 |
| Comparative study of the virus neutralising antibody levels and types of skin reaction in smallpox revaccinated persons | Svet-Moldavskaya IA, Marennikova SS, Akatova-Shelukhina EM, Ogorodnikova ZI | Smallpox/WP/25 | WHO: 10665/67679 |
| The relation between potency of vaccine used in smallpox vaccination and immunity produced | Polak MF | Smallpox/WP/9 | WHO: 10665/67699 |
| Immunity in relation to the number of insertions | Benenson AS | Smallpox/WP/21 | WHO: 10665/67675 |
| Laboratory aspects | Downie AW | Smallpox/WP/2 | WHO: 10665/67660 |
| Bleeding and coagulation studies in smallpox and chicken-pox, Madras, India, 1962-63 | Kempe CH | Smallpox/WP/5 | WHO: 10665/67694 |
| The viruses of variola major, variola minor and atypical strains | Downie AW | Smallpox/WP/14 | WHO: 10665/67665 |
| Smallpox vaccines | Kaplan C | Smallpox/WP/10 | WHO: 10665/67661 |
| A comparison of vaccinia virus strains used for production in various countries | Marennikova SS, Nal'ceva NN | Smallpox/WP/16 | WHO: 10665/67672 |
| The composition of genetically heterogeneous smallpox vaccines and methods of purifying them | Marennikova SS, JZ Genden, Nal'ceva NN,FB Genkins, VI Čornos | Smallpox/WP/23 | WHO: 10665/67677 |
| Chemoprophylaxis and chemotherapy | Downie AW, Kempe CH | Smallpox/WP/3 | WHO: 10665/67692 |
| The use of vaccinia hyperimmune gamma-globulin in the prophylaxis of smallpox | Kempe CH | Smallpox/WP/4 | WHO: 10665/67693 |
| Hyperimmune antivaccinia gamma globulin from animal sera | Marennikova SS, Akatova-Shelukhina EM, Maltseva NN, Ghenkina PB, VN Milushkin, Miniovich FL | Smallpox/WP/24 | WHO: 10665/67693 |
| Criterion for smallpox eradication | WHO | Smallpox/WP/11 | WHO: 10665/67662 |
| The planning, organization and execution of smallpox vaccination campaign in Pakistan | Haque NS | Smallpox/WP/13 | WHO: 10665/67664 |
| Planning, organization and execution of national smallpox eradication campaign in India | Lal KM | Smallpox/WP/19 | WHO: 10665/67673 |
| Assessment and evaluation of the national smallpox eradication programme in different parts of India | Lal KM | Smallpox/WP/26 | WHO: 10665/67680 |
| Smallpox eradication programme in Ghana | Grant FC | Smallpox/WP.20 | WHO: 10665/67674 |
| Measures to be taken in case of outbreaks in countries free from smallpox | Polak MF | Smallpox/WP/8 | WHO: 10665/67698 |
| International certificate of vaccination or revaccination against smallpox | WHO | Smallpox/WP/6 | WHO: 10665/67695 |
This was the first seminar conducted by the SEP. It included national and WHO staff from 13 countries of the South-East Asia, Eastern Mediterranean, and Western Pacific Regions. The few surviving documents were found among DA Henderson's personal papers. This compiled Conference document includes:
A 1967 WHO survey of vaccine concluded that not more than 10% of the vaccine used in endemic countries met WHO standards. The urgent need to simultaneously improve vaccine production in at least 20 laboratories prompted the Smallpox Eradication unit to convene a panel of experts. The working papers below were presented at the first meeting (WHO, Geneva, Switzerland, 19-23 Mar). The panel visited and reviewed vaccine production and data at major vaccine contributors in the US and USSR. A manual on freeze-dried smallpox vaccine production was prepared at a second meeting (Wyeth Laboratories, Philadelphia PA, 28-30 Mar).
The manual, Methodology of Freeze-dried Smallpox Vaccine Production (SE/68.3 Rev.2), provided a step-by-step description of the simplest procedures for all stages of production and testing of a potent, stable, and safe vaccine. Never officially published by WHO, it was made widely available as a document of the Smallpox Eradication unit. It was distributed to all laboratories interested in the production of vaccine.
Note: Individual papers have not yet been located but are listed because of their significance to the programme.
| Title | Authors | Source | URL |
|---|---|---|---|
| List of participants and working papers | SE/68.3 Rev.2 Appendix 19 | DAH: Chesney Med Arch | |
| Methodology of freeze-dried smallpox vaccine production | Kaplan C, Hekker AC | WP/1 | |
| The International Reference preparation of smallpox vaccine | WP/2 | ||
| Stability and preservability of freeze-dried smallpox vaccine with different moisture contents | Nomura M et al. | WP/3 | |
| Relation of the PFU value to the volume of inoculum in the titration of vaccinia virus on the chorio-allantoic membrane of the chick embryo | Slonim D | WP/4 | |
| Recommendations relating to the manufacture of smallpox vaccine | WP/5 | ||
| Status of freeze-dried vaccine production | WHO | WP/6 | |
| Comparison of capacities of various freeze-dryers | WHO | WP/7 | |
| Effect of 1% phenol on several bacterial and viral species | Slonim D | ||
| Attempt to utilize 1% phenol for bacterial sterilization of calf lymph smallpox vaccine | Slonim D | WP/9 | |
| Phenolization of smallpox vaccine | Hekker AC | WP/10 | |
| An alternate heat stability test | Hekker AC | WP/11 | |
| Vaccine production data - Rijks Instituut | Hekker AC | WP/12 | |
| Stability of reconstituted vaccine | Hekker AC | WP/13 | |
| A note on the preservation of the infectious activity of vaccinia virus by means of glycerine | Slonim D | WP/14 | |
| Some factors influencing quality and quantity of infectious pulp yields in calf skin inoculated with vaccinia virus | Slonim D | WP/15 | |
| Vaccinia virus stability during storage in fluid suspension at +2°C to +4°C , during lyophilization procedure and during storage in lyophilized form at +37°C | Slonim D | WP/16 | |
| The influence of the atmosphere of sealing on the stability of freeze-dried smallpox vaccine | Kaplan C | WP/17 | |
| Virus strains for smallpox vaccine production | Marennikova SS | WP/18 | |
| Production method for freeze-dried smallpox vaccine | Fenje P | WP/20 | |
| Stability study on freeze-dried vaccine exposed to room atmosphere before sealing | Schneider R | WP/21 | |
| Results of heat resistance testing at 37°C and 45°C of RIV Vaccine 6664 reconstituted with diluents of different glycerine contents | Hekker AC | WP/22 | |
| Stability of smallpox vaccine freeze-dried with or without stabilizers and sealed under different conditions | Hekker AC | WP/23 | |
| Information regarding vaccine production - Connaught Medical Research Laboratory | Wilson RJ | WP/24 | |
| Dryvax® - Production and control testing experience | Bernstein A | WP/25 | |
| Four extracts from papers dealing with miscellaneous aspects of freeze-dried smallpox vaccine production | WP/26 | ||
| Production of smallpox vaccine on calf skin with different strains of vaccinia virus | Hekker AC | WP/27. | |
| Vaccine production data - Research Institute of Virus Preparations, USSR | Marennikova SS | WP/28 | |
| Stability of dried smallpox vaccine at various temperatures | Fenje P | WP/29 | |
| Smallpox·vaccine production in a limited number of passages in one animal species | Marennikova SS, Milushin VN, Chimishkyan KL | WP/30 | |
| Notes on smallpox vaccine production methods in South American laboratories | Fenje P | WP/31 |
This early meeting of WHO Regional Advisers discussed the programme's plans and needs, providing recommendations for WHO and its Regional Offices. The appointment of a full-time Regional Smallpox Eradication Adviser was requested. The surviving documents below are from DA Henderson's personal papers:
Southern and Eastern Africa
| Title | Authors | Source | URL |
|---|---|---|---|
| [Participants and programme] French | DA Henderson personal archives | DAH: Chesney Med Arch | |
| Opening speech (planned) [as delivered several days late] |
DA Henderson personal archives | DAH: Chesney Med Arch [DAH: Chesney Med Arch |
|
| Status of smallpox eradication activities (sample data form) | SE/68.4 | WHO: 10665/67969 | |
| Status of smallpox eradication activities: Botswana | SE/68.13 | WHO: 10665/67949 | |
| Status of smallpox eradication activities: DR Congo | SE/68.11 | WHO: 10665/67945 | |
| Status of smallpox eradication activities: Kenya | SE/68.18 | WHO: 10665/67959 | |
| Status of smallpox eradication activities: Malawi | SE/68.15 | WHO: 10665/67953 | |
| Status of smallpox eradication activities: Sudan | SE/68.20 | WHO: 10665/67964 | |
| Status of smallpox eradication activities: Tanzania | SE/68.10 | WHO: 10665/67943 | |
| Status of smallpox eradication activities: Uganda | SE/68.12 | WHO: 10665/67947 | |
| Status of smallpox eradication activities: Zambia | SE/68.14 | WHO: 10665/67951 | |
| TRAINING | |||
| Instructions and sample data form for field assessment | SE/68.16, SE/68.17 | DAH: Chesney Med Arch | |
| Title | Authors | Source | URL |
|---|---|---|---|
| Provisional agenda | DAH: Chesney Med Arch | ||
| Recommendation | DAH: Chesney Med Arch | ||
|
|
|||
| PROCEEDINGS - Part I [10.5 MB] | CDC, SEP Report 1970 IV(1):1-66 | DAH: Chesney Med Arch | |
| Dedication, preface, participants, table of contents, opening of the conference | CDC, SEP Report IV(1):1-8 | DAH: Chesney Med Arch | |
| INTRODUCTION | |||
| The global status of smallpox eradication | Henderson DA | CDC, SEP Report IV(1):10-20 | DAH: Chesney Med Arch |
| Development and status of the Smallpox Eradication and Measles Control Programme in West Africa | Millar JD | CDC, SEP Report IV(1):21-27a | DAH: Chesney Med Arch |
| SMALLPOX | |||
| Epidemiology of smallpox in West and Central Africa | WH Foege | CDC, SEP Report IV(1):29-35a | DAH: Chesney Med Arch |
| Execution of smallpox eradication-measles control programme in Guinea | Barry El-Hadj A | CDC, SEP Report IV(1):36-40 | DAH: Chesney Med Arch |
| Results of investigation and control programme in Sierra Leone | Cummings EC, Hopkins DR, Thornton JN | CDC, SEP Report IV(1):41-44 | DAH: Chesney Med Arch |
| Use of house-to-house surveys in finding smallpox cases | Agle AN | CDC, SEP Report IV(1):45-46 | DAH: Chesney Med Arch |
| Persistence of smallpox in remote unvaccinated villages | Imperato P, Sow O, LaPointe M, Vastine D, TA Leonard | CDC, SEP Report IV(1):47-51 | DAH: Chesney Med Arch |
| Associated with exposure at a funeral ceremony: Smallpox outbreak, Yawei Chiefdom, Kailahun District, Sierra Leone | Cummings EC, Hopkins DR, Thornton JN | CDC, SEP Report IV(1):52-54 | DAH: Chesney Med Arch |
| Role of migrant groups in the transmission of smallpox in Mali | Sow O | CDC, SEP Report IV(1):55-56 | DAH: Chesney Med Arch |
| A study of smallpox in the Tuaregs in Tahoua, Niger | Masso AR | CDC, SEP Report IV(1):57-58 | DAH: Chesney Med Arch |
| Notes on variolation | Glokpor GF | CDC, SEP Report IV(1):59-61 | DAH: Chesney Med Arch |
| The role of fetish practices in vaccination campaigns | Robbins GE | CDC, SEP Report IV(1):62-64 | DAH: Chesney Med Arch |
| Summary: Smallpox | Millar JD | CDC, SEP Report IV(1):65-66 | DAH: Chesney Med Arch |
|
|
|||
| PROCEEDINGS - Part 2 [19.4 MB] | CDC, SEP Report 1970 IV(2):1-225 | DAH: Chesney Med Arch | |
| Table of contents | CDC, SEP Report IV(2):1-2 | DAH: Chesney Med Arch | |
| MEASLES | |||
| Epidemiological characteristics of measles in West and Central Africa | Millar JD | CDC, SEP Report IV(2):4-8 | DAH: Chesney Med Arch |
| Measles in Douala | Peters B, Delas A | CDC, SEP Report IV(2):9-14 | DAH: Chesney Med Arch |
| Bouar measles epidemic, Central African Republic | Ewen N | CDC, SEP Report IV(2):15-18 | DAH: Chesney Med Arch |
| Measles in Lagos, Nigeria | Smith EA, Daniels SO, Foster SO | CDC, SEP Report IV(2):19-26 | DAH: Chesney Med Arch |
| Measles epidemic near Salo, Central African Republic | Durand B | CDC, SEP Report IV(2):27-29 | DAH: Chesney Med Arch |
| Measles in areas of malnutrition | Smith EA, Foster SO | CDC, SEP Report IV(2):30-36 | DAH: Chesney Med Arch |
| A comparison of measles virus vaccines | Hendrickse RG | CDC, SEP Report IV(2):37-39 | DAH: Chesney Med Arch |
| Measles vaccination with reduced dosage [Based on Hendrickse RG, Montefiore D: Measles vaccination with reduced dosage. Brit Med J 1968 4:28-30] |
Hendrickse RG | CDC, SEP Report IV(2):40-43 | DAH: Chesney Med Arch |
| SURVEILLANCE | |||
| Smallpox surveillance in the strategy of global eradication | Henderson DA | CDC, SEP Report IV(2):46-52 | DAH: Chesney Med Arch |
| The value of surveillance newsletters | Smith EA, Foster SO | CDC, SEP Report IV(2):53-57 | DAH: Chesney Med Arch |
| The surveillance system and methods used to improve reporting, I. Togo | Agbodjan LP | CDC, SEP Report IV(2):58-59 | DAH: Chesney Med Arch |
| The surveillance system and methods used to improve reporting, II. Dahomey | Yekpe M | CDC, SEP Report IV(2):60-62 | DAH: Chesney Med Arch |
| The surveillance system and methods used to improve reporting, III. Niger | Alzouma I | CDC, SEP Report IV(2):63-65 | DAH: Chesney Med Arch |
| Surveillance techniques for detecting importations of smallpox | Grant FC | CDC, SEP Report IV(2):66-68 | DAH: Chesney Med Arch |
| Assessment of surveillance systems in West Africa | Henderson RH | CDC, SEP Report IV(2):69-72 | DAH: Chesney Med Arch |
| Summary: Surveillance | Henderson DA | CDC, SEP Report IV(2):73-74 | DAH: Chesney Med Arch |
| INTERCOUNTRY COORDINATION | |||
| Intercountry cooperation and coordination. An overview | Lythcott GI | CDC, SEP Report IV(2):76-77 | DAH: Chesney Med Arch |
| Proposals for intercountry coordination | Tchellé L | CDC, SEP Report IV(2):78-79 | DAH: Chesney Med Arch |
| Experiences in Upper Volta with intercountry coordination of containment activities | d'Amanda C | CDC, SEP Report IV(2):80-81 | DAH: Chesney Med Arch |
| Benefits of intercountry coordination | Agle AN | CDC, SEP Report IV(2):82 | DAH: Chesney Med Arch |
| ASSESSMENT | |||
| Principles of assessment | Henderson RH | CDC, SEP Report IV(2):86-89 | DAH: Chesney Med Arch |
| Concurrent assessment during the smallpox eradication/measles control programme in Guinea - December 1967 through February 1969 | Alécaut B, Breman JG, Famba MK | CDC, SEP Report IV(2):90-96 | DAH: Chesney Med Arch |
| Concurrent assessment of the Smallpox Eradication Programme in Mid-West State, Nigeria | Mebitaghan IS, Okoh PA | CDC, SEP Report IV(2):97-102 | DAH: Chesney Med Arch |
| Assessment in the Central African Republic | Ewen N | CDC, SEP Report IV(2):103-108 | DAH: Chesney Med Arch |
| Assessment of vaccination coverage and smallpox in five areas of West Africa. A summary of terminal assessment results | Henderson RH, Davis H, Eddins D | CDC, SEP Report IV(2):109-132 | DAH: Chesney Med Arch |
| Summary: Concurrent assessment | Millar JD | CDC, SEP Report IV(2):133-135 | DAH: Chesney Med Arch |
| MAINTENANCE PROGRAMMES: MEASLES | |||
| Introduction: Principles and goals of maintenance programmes | Millar JD | CDC, SEP Report IV(2):138-139 | DAH: Chesney Med Arch |
| Measles control in The Gambia | N'Dow PJ, Helmholz RC | CDC, CDC, SEP Report IV(2):140-144 | DAH: Chesney Med Arch |
| Urban measles control | Adetosoye JI | CDC, CDC, SEP Report IV(2):145-148 | DAH: Chesney Med Arch |
| The measles control programme in Dakar, Senegal | Seck M, Helmholz RC | CDC, SEP Report IV(2):149-150 | DAH: Chesney Med Arch |
| Maintenance of measles control in Kano State, Nigeria | Arnold RB | CDC, SEP Report IV(2):151-156 | DAH: Chesney Med Arch |
| Measles control in areas of low population density | Gilles JC | CDC, SEP Report IV(2):157-160 | DAH: Chesney Med Arch |
| Alternative approaches to measles control using fixed centres | Thompson DM | CDC, SEP Report IV(2):161-164 | DAH: Chesney Med Arch |
| Theoretical and practical problems in measles control | Millar JD | CDC, SEP Report IV(2):165-176 | DAH: Chesney Med Arch |
| MAINTENANCE PROGRAMMES: SMALLPOX | |||
| Smallpox eradication in Africa: Principles for action in the maintenance phase | Binson B | CDC, SEP Report IV(2):177-180 | DAH: Chesney Med Arch |
| Maintenance of smallpox immunity among the nomads | Alzouma I | CDC, SEP Report IV(2):181-182 | DAH: Chesney Med Arch |
| Investigation of imported cases during the Smallpox Eradication Programme in Cameroon | Delas A | CDC, SEP Report IV(2):183-187 | DAH: Chesney Med Arch |
| Summary: Maintenance programmes | Millar JD | CDC, SEP Report IV(2):188-189 | DAH: Chesney Med Arch |
| PROGRAMME OPERATIONS | |||
| A review of West African operations: Methods and tactics | Hicks JW | CDC, SEP Report IV(2):192-198 | DAH: Chesney Med Arch |
| The value, efficiency, and limitations of collecting points in mass vaccination programmes | Smith EA, Foster SO, Adetosoye JI, Mebitaghan IS, Adeoye PO, Pifer JM | CDC, SEP Report IV(2):199-204 | DAH: Chesney Med Arch |
| Comparative advantages of jet injectors and bifurcated needles | Glokpor GF | CDC, SEP Report IV(2):205-207 | DAH: Chesney Med Arch |
| Advantages and disadvantages of specialized and multi-purpose medical teams | Roux JM | CDC, SEP Report IV(2):208-212 | DAH: Chesney Med Arch |
| Safety, efficacy, and priorities in multiple antigen usage | Hendrickse RG | CDC, SEP Report IV(2):213-215 | DAH: Chesney Med Arch |
| Associated vaccine campaigns. Organization and logistics | Labusquière R | CDC, SEP Report IV(2):216-220 | DAH: Chesney Med Arch |
| Programme costs as related to vaccinations, morbidity and mortality in The Gambia | N'Dow PJ | CDC, SEP Report IV(2):221-223 | DAH: Chesney Med Arch |
| Summary: Programme operations | Henderson DA | CDC, SEP Report IV(2):224-225 | DAH: Chesney Med Arch |
|
|
|||
| Status of smallpox eradication programme, May 1969 | SE/69.20 | DAH: Chesney Med Arch | |
| Status of smallpox eradication activities (sample data form) | SE/69.6 Rev 1 | DAH: Chesney Med Arch | |
| Country Report: Cameroon | SE/69.10 | DAH: Chesney Med Arch | |
| Country Report: Central African Republic | SE/69.17 | DAH: Chesney Med Arch | |
| Country Report: Chad | SE/69.15 | DAH: Chesney Med Arch | |
| Country Report: Dahomey (Benin) | SE/69.18 | DAH: Chesney Med Arch | |
| Country Report: Gabon | SE/69.14 | DAH: Chesney Med Arch | |
| Country Report: The Gambia | SE/69.16 | DAH: Chesney Med Arch | |
| Country Report: Ghana | SE/69.9 | DAH: Chesney Med Arch | |
| Country Report: Guinea | SE/69.21 | DAH: Chesney Med Arch | |
| Country Report: Liberia | SE/69.13 | DAH: Chesney Med Arch | |
| Country Report: Mali | SE/69.23 | DAH: Chesney Med Arch | |
| Country Report: Niger | SE/69.19 | DAH: Chesney Med Arch | |
| Country Report: Nigeria | SE/69.22 | DAH: Chesney Med Arch | |
| Country Report: Nigeria (Northern States) | SE/69.24 | DAH: Chesney Med Arch | |
| Country Report: Senegal | SE/69.11 | DAH: Chesney Med Arch | |
| Country Report: Sierra Leone | SE/69.8 | DAH: Chesney Med Arch | |
| Country Report: Togo | SE/69.12 | DAH: Chesney Med Arch | |
| Country Report: Upper Volta (Burkina Faso) | SE/69.25 | DAH: Chesney Med Arch | |
South-East Asia, Eastern Mediterranean, and African Regions
| Title | Authors | Source | URL |
|---|---|---|---|
| PROCEEDINGS | WHO/SE/71.30:1-243 13.6MB |
WHO: 10665/67488 | |
| Preface and table of contents | WHO/SE/71.30:002-4 | DAH: Chesney Med Arch | |
| STATUS OF THE SMALLPOX ERADICATION PROGRAMME | |||
| Summary - Status of the global programme | Henderson DA | WHO/SE/71.30:6-12 [also issued as SE/WP/70.1] |
DAH: Chesney Med Arch [WHO: 10665/68046 |
| Review of the status of smallpox in the South-East Asia Region | Oles A | WHO/SE/71.30:13-23 [also issued as SE/WP/70.3] |
DAH: Chesney Med Arch [WHO: 10665/68072 |
| Status of the smallpox eradication programmes in the Eastern Mediterranean Region | Shafa E | WHO/SE/71.30:24-30 | DAH: Chesney Med Arch |
| AFRICA | |||
| The Smallpox Eradication Programme in Sierra Leone | Cummings EC | WHO/SE/71.30:32-44 [also issued as SE/WP/70.7] |
DAH: Chesney Med Arch [WHO: 10665/68077[ |
| Recurrence of smallpox in Nigeria 1970 | Foege WH | WHO/SE/71.30:45-51 [also issued as WHO/SE/76.85 Annex III] |
DAH: Chesney Med Arch |
| Problems of border areas in West Africa | Foege WH | WHO/SE/71.30:52-8 | DAH: Chesney Med Arch |
| BRAZIL | |||
| Surveillance in the Brazilian smallpox eradication programme, 1970 | de Faria GB, de Carvalho Filho EC, Rodrigues BA, Ponce de Leon J | WHO/SE/71.30:60-70 | DAH: Chesney Med Arch |
| Investigation of hospital-associated smallpox: Vitoria, Espirito Santo | Morris L, de Lemos AL, da Silva OJ | WHO/SE/71.30:71-8 | DAH: Chesney Med Arch |
| AFGHANISTAN | |||
| Smallpox surveillance in Afghanistan | Rangaraj AG | WHO/SE/71.30:80-91 [also issued as SE/WP/70.24] |
DAH: Chesney Med Arch [WHO: 10665/68065] |
| Special problems relating to the smallpox eradication programme in Afghanistan | Akbary MT | WHO/SE/71.30:92-97 [also issued as SE/WP/70.22] |
DAH: Chesney Med Arch [WHO: 10665/68063] |
| Assessment of the smallpox vaccination program in Afghanistan | Salehi MY | WHO/SE/71.30:98-102 [also issued as SE/WP/70.28] |
DAH: Chesney Med Arch [WHO: 10665/68070] |
| BURMA, NEPAL | |||
| International cooperation in the smallpox eradication programme [Outbreaks in Burma in 1968 and 1969] | Thaung U, Myat UA | WHO/SE/71.30:104-7 | DAH: Chesney Med Arch |
| Importation of smallpox cases into Nepal | Shrestha PN | WHO/SE/71.30:108-10 [also issued as SE/WP/70.21] |
DAH: Chesney Med Arch [WHO: 10665/68062] |
| INDONESIA | |||
| The establishment of an effective reporting system in Indonesia | Karyadi A | WHO/SE/71.30:112-6 [also issued as SE/WP/70.4] and SE/WP/74.4] |
DAH: Chesney Med Arch [WHO: 10665/68076] |
| Is routine vaccination necessary in a smallpox eradication programme? | Koswara PA | WHO/SE/71.30:117-25 [also issued as SE/WP/70.13] and SE/WP/74.5] |
DAH: Chesney Med Arch [WHO: 10665/68049] |
| The twenty years and the twenty months | Arbani PR | WHO/SE/71.30:126-9 [also issued as SE/WP/70.9] and SE/WP/74.6] |
DAH: Chesney Med Arch [WHO: 10665/68078] |
| Low-level transmission of smallpox in a well vaccinated area, Pasar Minggu, Djakarta, Indonesia (February-August 1970) | Emmet W | WHO/SE/71.3:130-3 [also issued as SE/WP/70.29] and SE/WP/74.7] |
DAH: Chesney Med Arch [WHO: 10665/68071] |
| Smallpox in Djakarta Residency, 1970 | Hartohusodo R | WHO/SE/71.30:134-9 [also issued as SE/WP/74.8] |
DAH: Chesney Med Arch |
| What went wrong in Loning? | Arbani PR | WHO/SE/71.30:140-4 [also issued as SE/WP/74.9] |
DAH: Chesney Med Arch |
| INDIA | |||
| Observations during special investigations in Rajasthan | Singh M | WHO/SE/71.30:146-60 [also issued as SE/WP/70.12] |
DAH: Chesney Med Arch [WHO: 10665/68048] |
| Development of the Smallpox Eradication Programme in Andhra Pradesh State, India | Apparao MV | WHO/SE/71.30:161-73 [also issued as SE/WP/71.27] |
DAH: Chesney Med Arch [WHO: 10665/67485] |
| The pattern of urban smallpox—Calcutta | Sarkar JK | WHO/SE/71.30:174-80 [also issued as SE/WP/70.15] |
DAH: Chesney Med Arch [WHO: 10665/68050] |
| PAKISTAN | |||
| Surveillance of smallpox in East Pakistan | Markvart K, Huq AMM, Islam AIMS | WHO/SE/71.30:182-94 | DAH: Chesney Med Arch |
| Surveillance activities of the Smallpox Eradication Programme in West Pakistan | Khawaja MB, Adibzadeh F | WHO/SE/71.30:195-206 [also issued as SE/WP/70.11] |
DAH: Chesney Med Arch [WHO: 10665/68047] |
| TECHNICAL CONSIDERATIONS | |||
| Vaccination of hospitalized patients and newborns: contraindications to vaccination | Rao AR | WHO/SE/71.30:208-18 [also issued as SE/WP/70.16] |
DAH: Chesney Med Arch] |
| Vaccine, production, storage and handling | Henderson DA | WHO/SE/71.30:219-22 [also issued as SE/WP/70.17] |
DAH: Chesney Med Arch [WHO: 10665/68052] |
| Tools and techniques in smallpox vaccination | Shafa E | WHO/SE/71.30:223-8 [also issued as SE/71.4 (French)] |
DAH: Chesney Med Arch [WHO: 10665/68030]] |
| RECOMMENDATIONS OF THE CONFERENCE | WHO/SE/71.30:229-32 | DAH: Chesney Med Arch | |
| LIST OF PARTICIPANTS | WHO/SE/71.30:233-43 | DAH: Chesney Med Arch | |
|
|
|||
| TEACHING EXERCISE | |||
| Introductory remarks | Henderson DA | SE/WP/70.30 | WHO: 10665/68073 |
| Teaching exercise. Field investigation. Problem for students; Syllabus for the discussion leaders | SE/WP/70.31, SE/WP/70.31a | WHO: 10665/68074 WHO: 10665/68075 |
|
| Assessment of the vaccination component of the programme. From Handbook for Smallpox Eradication in Endemic Areas (rev) | SE/WP/70.25 | WHO: 10665/68067 | |
| Scar surveys as a tool for evaluation and supervision of the smallpox eradication programme, East Java Province, Indonesia | Witjaksono H | SE/WP/70.26 | WHO: /iris.who.int/handle/10665/68068 |
| Scar survey in smallpox eradication programme of West Pakistan | Khawaja MB, Adibzadeh F | SE/WP/70.27 | WHO: 10665/68069 |
South-East Asia Region
| Title | Authors | Source | URL |
|---|---|---|---|
| Programme | SE/WP/72(1) | DAH: Chesney Med Arch | |
| List of participants | SE/WP/72(2) | DAH: Chesney Med Arch | |
|
|
|||
| Inaugural address | Chattopadhyaya DP | SE/WP/72(3) | WHO: 10665/68081 |
| Opening remarks | Henderson DA | SE/WP/72(4) | WHO: 10665/68082 |
| The global smallpox eradication programme - the final phase | Henderson DA | SE/WP/72(7) | WHO: 10665/68085 |
| Smallpox eradication in Asia | Grasset NC | SE/WP/72(8) | WHO: 10665/68086 |
| PRESENT STATUS AND FUTURE PLANS FOR COUNTRY PROGRAMMES | |||
| The present status and future plans for the Bangladesh programme | Huq AMM, Kashem JA, Khan A, Arnt N | SE/WP/72.7 | WHO: 10665/68107 |
| A report on the present smallpox status in Bhutan | Samdup PW | SE/WP/72.18 | WHO: 10665/68096 |
| Present status and future plan of smallpox eradication programme in India | Basu RN | SE/WP/72.8 | WHO: 10665/68108 |
| Present status and future plans for the smallpox eradication programme in Nepal | Shrestha PN | SE/WP/72.12 | WHO: 10665/68090 |
|
|
|||
| Development of a reporting system in Uttar Pradesh | Dube RD | SE/WP/72.16 | WHO: 10665/68094 |
| Development of reporting system in Nepal | Shrestha PN | SE/WP/72.13 | WHO: 10665/68091 |
| Consequences of poor reporting: An experience encountered in Gulbarga District, Mysore State, South India | Rao RR | SE/WP/72.19 | WHO: 10665/68097 |
| Cross notification in smallpox eradication | Rao MCA | SE/WP/72.20 | WHO: 10665/68099 |
| Tracing of the source of infection | Singh I | SE/WP/72.5 | WHO: 10665/68104 |
|
|
|||
| Problems of smallpox diagnosis | Zacharias J | SE/WP/72.17 | WHO: 10665/68095 |
| The role of the diagnostic laboratory | Henderson DA | SE/WP/72(6) | WHO: 10665/68084 |
|
|
|||
| Conquest of smallpox in Maharashtra State: Containment and follow-up measures; failures and achievements | Aphale RV | SE/WP/72.9 | WHO: 10665/68109 |
| "Encourage and appreciate immediate reporting of smallpox": Methods to determine the efficacy of the programme | Ahuja AS | SE/WP/72.3 | WHO: 10665/68102 |
| Use of surveillance teams in Rajasthan | Aggarwal ML, Jagdev DK, Monnier A | SE/WP/72.10 | WHO: 10665/68088 |
| The use of surveillance teams in Bangladesh | Huq AMM, Kashem JA | SE/WP/72.15 | WHO: 10665/68093 |
| Methods to ascertain the smallpox transmission in an area has been interrupted | Verma SD | SE/WP/72.4 | WHO: 10665/68103 |
|
|
|||
| The control of smallpox in greater Bombay | Parulekar DV | SE/WP/72.2 | WHO: 10665/68098 |
| Control of smallpox in Delhi Municipal Corporation | Jeswani PH | SE/WP/72.14 | WHO: 10665/68092 |
| Epidemic smallpox in a rural district (Santhal Parganas) | Mouar DPS | SE/WP/72.21 | WHO: 10665/68101 |
| Neo-natal vaccination | Kapali V | SE/WP/72.1 | WHO: 10665/68101 |
| Virus excretion in the throat, urine and conjunctiva of smallpox cases | Sarkar JK, Mitra AC, Mukherjee MK, De S, Mazumdar DG | SE/WP/72.11 | WHO: 10665/68089 |
| The need for revaccination in national smallpox eradication programmes and of laboratory diagnosis | Pattanayak S, Sehgal PN | SE/WP/72.A | WHO: 10665/68100 |
|
|
|||
| Recommendations formulated by the committee | SE/WP/72(5) | DAH: Chesney Med Arch | |
Eastern Mediterranean Region
| Title | Authors | Source | URL |
|---|---|---|---|
| Inauguration of the seminar | Henderson DA | SE/72.9 | WHO: 10665/68042 |
| Smallpox eradication project Punjab 1972. Some aspects of smallpox eradication in Lahore | Suleimanov GD | SE/WP/PAK/72.1 | WHO: 10665/68165 |
| The problem of variolating relating to the smallpox eradication programme in Afghanistan | Rangaraj AG | SE/WP/PAK/72.2 | WHO: 10665/68166 |
| The smallpox eradication programme in Afghanistan | Darmanger AM, Rangaraj AG | SE/WP/PAK/72.3 | WHO: 10665/68167 |
| Smallpox eradication programme Punjab 1972. Three years of experience in Punjab Province [Pakistan] | Suleimanov GD, Rafique M | SE/WP/PAK/72.4 | WHO: 10665/68169 |
| The global smallpox eradication programme—The final phase | Henderson DA | SE/72.10 | WHO: 10665/68031 |
| Title | Authors | Source | URL |
|---|---|---|---|
| Assignment report on smallpox eradication, Indonesia, 4-31 Aug 1973 | Wehrle PF | SE/WP/74.1 [also issued as SEA/Smallpox/71] |
WHO: 10665/68111 |
| Smallpox control in Indonesia during the second quarter of the century and re-establishment of endemic smallpox from 1947 | Polak MF | SE/WP/74.2 [also issued as SE/WP/68.1 and Trop Geogr Med 1974 20(3):243-50] |
WHO: 10665/68112 [WHO: 10665/67458] |
| The smallpox eradication programme in Indonesia | Setiady IF | SE/WP/74.3 [also issued as SE/WP/71.71] |
WHO: 10665/68113 |
| The establishment of an effective reporting system for smallpox in Indonesia | Karyadi A | SE/WP/74.4 [also issued as SE/WP/70.4 and WHO/SE/71.30 pp 112-6] |
DAH Chesney Med Arch [WHO: 10665/68076] [WHO: 10665/67488[ |
| Is routine vaccination a necessity in a smallpox eradication programme? | Koswara PA | SE/WP/74.5 [also issued as SE/WP/70.13 and WHO/SE/71.30 pp 117-25] |
WHO: /iris.who.int/handle/10665/68115 [WHO: /iris.who.int/handle/10665/68049] [WHO: /iris.who.int/handle/10665/67488] |
| The twenty years and the twenty months | Arbani PR | SE/WP/74.6 [also issued as SE/WP/70.9] and WHO/SE/71.30 pp 126-9] |
WHO: 10665/68116 [WHO: /iris.who.int/handle/10665/68078] [WHO: /iris.who.int/handle/10665/67488] |
| Low-level transmission in a well-vaccinated area, Pasar Minggu, Jakarta, Indonesia (February - August 1970) | Emmet W | SE/WP/74.7 [also issued as SE/WP/70.29] and WHO/SE/71.30 pp 130-3] |
WHO: 10665/68117 [WHO: /iris.who.int/handle/10665/68071] [WHO: /iris.who.int/handle/10665/67488] |
| Smallpox in Jakarta Residency, 1970 | Hartohusodo R | SE/WP/74.8 [also issued as WHO/SE/71.30 pp 134-9] |
WHO: 10665/68118 [WHO: /iris.who.int/handle/10665/67488] |
| What went wrong in Loning? | Arbani PR | SE/WP/74.9 [also issued as WHO/SE/71.30 pp 140-4] |
WHO: 10665/68119 [WHO: /iris.who.int/handle/10665/67488] |
| Indonesia 1972: Some smallpox surveillance patterns | Cuboni GGO, Emmet W, Rai NK, Karyadi A, Setiady IF | WHO/SE/74.63 | WHO: 10665/67629 |
| Indonesia 1971/72: Smallpox vaccinators as surveillance workers | Cuboni GGO, Emmet W, Koswara PA, Rai NK, Karyadi A, Setiady IF | WHO/SE/74.66 | WHO: 10665/67636 |
| Report of the WHO International Commission on Assessment of Smallpox Eradication in Indonesia, 25 April 1974 | WHO/SE/74.68 | WHO: 10665/67640 |
| Title | Authors | Source | URL |
|---|---|---|---|
| Report of the International Commission for the Certification of Smallpox Eradication in Somalia, 1-21 October 1979 | WHO/SE/79.146 | WHO: 10665/68279 | |
| Report of the International Commission for the Certification of Smallpox Eradication in Djibouti, 9-18 October 1979 | WHO/SE/79.147 | WHO: 10665/68280 | |
| Report of the International Commission for the Certification of Smallpox Eradication in Ethiopia, 1-17 October 1979 | WHO/SE/79.148 | WHO: 10665/68281 | |
| Report of the International Commission for the Certification of Smallpox Eradication in Kenya, 1-19 October 1979 | WHO/SE/79.149 | WHO: 10665/68282 | |
| Joint Report of the International Commission for the Certification of Smallpox Eradication in the Countries of the Horn of Africa, Nairobi, 26 October 1979 | WHO/SE/79.150 | WHO: 10665/68283 | |
| Address of Dr Halfdan Mahler, Director-General of WHO, 26 Oct 1979 [Draft annotated by DA Henderson] |
Mahler H | DA Henderson personal archives | DAH: Chesney Med Arch |
| Title | Authors | Source | URL |
|---|---|---|---|
| PROCEEDINGS [Publication supported by the Sabin Vaccine Institute] |
Breman JG, de Quadros CA, Gadelha P (eds) | Vaccine 2011 29(Suppl 4)D1-D164 |
URL: sciencedirect.com/journal/vaccine/vol/29/suppl/S4 |
| Editorial Board/Aims and scope | Vaccine 2011 29(Suppl 4):CO2 | DOI: 10.1016/S0264-410X(12)00272-1 | |
| INTRODUCTORY MATERIAL | |||
| Foreword | Roses-Periago M | Vaccine 2011 29(Suppl 4):D1-D2 | DOI: 10.1016/j.vaccine.2011.11.036 |
| Introduction: Meeting objectives, summary and final statement | Breman JG, de Quadros CA, Gadelha P | Vaccine 2011 29(Suppl 4):D3-D5 | DOI: 10.1016/j.vaccine.2011.11.037 |
| The eradication of smallpox--an overview of the past, present, and future | Henderson DA | Vaccine 2011 29(Suppl 4):D7-D9 | DOI: 10.1016/j.vaccine.2011.06.080 |
| LESSONS FROM SELECTED SMALLPOX-ENDEMIC COUNTRIES | |||
| Lessons and innovations from the West and Central African Smallpox Eradication Program | Foege W | Vaccine 2011 29(Suppl 4):D10-D12 | DOI: 10.1016/j.vaccine.2011.04.008 |
| Smallpox and its eradication in the Democratic Republic of Congo: Lessons learned | Muyembe-Tamfum J-J, Mulembakani P, Lekie RB, Szczeniowski M, ... Rimoin AW | Vaccine 2011 29(Suppl 4):D13-D18 | DOI: 10.1016/j.vaccine.2011.04.008 PMCID: PMC9628709 |
| Lessons from smallpox eradication campaign in Bihar state and in India | Dutta M, Basu RN | Vaccine 2011 29(11):2005-7 [reprinted in Vaccine 2011 29(Suppl 4):D19-D21] |
DOI: 10.1016/j.vaccine.2010.12.112 [DOI: 10.1016/j.vaccine.2011.12.001] |
| Smallpox eradication in Bangladesh, 1972–1976 | Foster SO, Hughes K, Tarantola D, Glasser JW | Vaccine 2011 29(Suppl 4):D22-D29 | DOI: 10.1016/j.vaccine.2011.06.081 PMCID: PMC5723923 |
| Experiences with smallpox eradication in Ethiopia | de Quadros CA | Vaccine 2011 29(Suppl 4):D30-D35 | DOI: 10.1016/j.vaccine.2011.10.001 |
| The emergency campaign for smallpox eradication from Somalia (1977-1979)--revisited | Deria A | Vaccine 2011 29 Suppl 4:D36-D40 | DOI: 10.1016/j.vaccine.2011.05.039 |
| The certification of smallpox eradication and implications for guinea worm, poliomyelitis, and other diseases: confirming and maintaining a negative | Breman JG, Arita I | Vaccine 2011 29(Suppl 4):D41-D48 | DOI: 10.1016/j.vaccine.2011.06.018 |
| ORTHOPOXVIRUSES: RESEARCH AND PUBLIC HEALTH IMPLICATIONS | |||
| Emergence and reemergence of smallpox: the need for development of a new generation smallpox vaccine | Shchelkunov SN | Vaccine 2011 29(Suppl 4):D49-53 | DOI: 10.1016/j.vaccine.2011.05.037 |
| Status of human monkeypox: clinical disease, epidemiology and research | Damon IK | Vaccine 2011 29(Suppl 4):D54-9 | DOI: 10.1016/j.vaccine.2011.04.014 |
| Whither monkeypox vaccination | Rimoin AW, Graham BS | Vaccine 2011 29(Suppl 4):D60-4 | DOI: 10.1016/j.vaccine.2011.09.004 PMCID: PMC3311705 |
| Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: a novel expanding zoonosis | Schatzmayr HG, Costa RV, Goncalves MC, D'Andrea PS, Barth OM | Vaccine 2011 29(Suppl 4):D65-9 | DOI: 10.1016/j.vaccine.2011.09.105 |
| ERADICATION AND CONTROL: PRINCIPLES AND LESSONS FOR PLANNING, IMPLEMENTATION, RESEARCH, AND EVALUATION | |||
| The principles and feasibility of disease eradication | Dowdle WR, Cochi SL | Vaccine 2011 29(Suppl 4):D70-3 | DOI: 10.1016/j.vaccine.2011.04.006 |
| The expanded programme on immunization: a lasting legacy of smallpox eradication | Okwo-Bele JM, Cherian T | Vaccine 2011 29(Suppl 4):D74-9 | DOI: 10.1016/j.vaccine.2012.01.080 |
| The global polio eradication initiative: lessons learned and prospects for success | Aylward B, Tangermann R | Vaccine 2011 29(Suppl 4):D80-5 | DOI: 10.1016/j.vaccine.2011.10.005 |
| Dracunculiasis eradication and the legacy of the smallpox campaign: what's new and innovative? What's old and principled? | Richards FO, Ruiz-Tiben E, Hopkins DR | Vaccine 2011 29(Suppl 4):D86-90 | DOI: 10.1016/j.vaccine.2011.07.115 |
| Measles and rubella eradication in the Americas | Andrus JK, de Quadros CA, Solorzano CC, Periago MR, Henderson DA | Vaccine 2011 29(Suppl 4):D91-6 | DOI: 10.1016/j.vaccine.2011.04.059 |
| The challenge of malaria eradication in the twenty-first century: research linked to operations is the key | Breman JG, Brandling-Bennett AD | Vaccine 2011 29(Suppl 4):D97-103 | DOI: 10.1016/j.vaccine.2011.12.003 |
| Enlarging the "Audacious Goal": elimination of the world's high prevalence neglected tropical diseases | Hotez P | Vaccine 2011 29(Suppl 4):D104-10 | DOI: 10.1016/j.vaccine.2011.06.024 |
| NEW VACCINE OPPORTUNITIES AND NEEDS IN THE 21st CENTURY | |||
| Vaccines of the future | Nossal GJ | Vaccine 2011 29(Suppl 4):D111-5 | DOI: 10.1016/j.vaccine.2011.06.089 |
| "IDEAL" vaccines for resource poor settings | Levine MM | Vaccine 2011 29 Suppl 4:D116-25 | DOI: 10.1016/j.vaccine.2011.11.090 |
| Strengthening surveillance: confronting infectious diseases in developing countries | Andrus JK, Solorzano CC, de Oliveira L, Danovaro-Holliday MC, de Quadros CA | Vaccine 2011 29(Suppl 4):D126-30 | DOI: 10.1016/j.vaccine.2011.06.023 |
| CROSS-CUTTING LESSONS FROM SMALLPOX AND LEGACY PROBLEMS | |||
| Logistics in smallpox: the legacy | Wickett J, Carrasco P | Vaccine 2011 29(Suppl 4):D131-4 | DOI: 10.1016/j.vaccine.2011.06.043 |
| From smallpox eradication to contemporary global health initiatives: enhancing human capacity towards a global public health goal | Tarantola D, Foster SO | Vaccine 2011 29(Suppl 4):D135-40 | DOI: 10.1016/j.vaccine.2011.07.027 |
| Surveillance in eradication and elimination of infectious diseases: a progression through the years | Heymann DL, Brilliant L | Vaccine 2011 29(Suppl 4):D141-4 | DOI: 10.1016/j.vaccine.2011.12.135 |
| GLOBAL PUBLIC HEALTH IN THE 21st CENTURY AND LESSONS FROM SMALLPOX ERADICATION | |||
| From smallpox eradication to the future of global health: Innovations, application and lessons for future eradication and control initiatives | Tomori O | Vaccine 2011 29(Suppl 4):D145-8 | DOI: 10.1016/j.vaccine.2011.09.003 |
| Health security and disease control: lessons from Mexico | Frenk J, Gomez-Dantes O | Vaccine 2011 29(Suppl 4):D149-51 | DOI: 10.1016/j.vaccine.2011.03.024 |
| The Jenner Society and the Edward Jenner Museum: tributes to a physician-scientist | Morgan AJ, Poland GA | Vaccine 2011 29(Suppl 4):D152-4 | DOI: 10.1016/j.vaccine.2011.08.128 |
| APPENDICES | |||
| SEC2010 Symposium Program Committee | Vaccine 2011 29(Suppl 4):D155 | DOI: 10.1016/j.vaccine.2011.11.039 | |
| Agenda | Vaccine 2011 29(Suppl 4):D156-D159 | DOI: 10.1016/j.vaccine.2011.11.040 | |
| Registered attendees | Vaccine 2011 29(Suppl 4):D160-D164 | DOI: 10.1016/j.vaccine.2011.11.041 | |
